COVID-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injection for phase III clinical trial

Aug 19, 2020

New Delhi [India], Aug 19 : The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's...

Battling viral Hepatitis in Rohingya camps amid mounting risk, resource crunch

Jun 20, 2024

Hepatitis B and Hepatitis C chronic infections can lead to serious consequences such as liver cirrhosis and cancer.

DCGI approves Itolizumab injection for restricted emergency use on COVID-19 patients

Jul 10, 2020

New Delhi [India], July 11 : The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use...

Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical trial

May 05, 2020

New Delhi [India], May 5 : The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila,...

Westernisation of diets, unhealthy sedentary lifestyle cause of fatty liver: AIIMS Delhi

Jul 28, 2023

Raising awareness against Hepatitis on the occasion of ‘World Hepatitis Day’, AIIMS Delhi on Friday, stressed upon the importance of having a healthy liver.

Hepatitis: The silent killer

Aug 28, 2020

New Delhi [India] Aug 28 (ANI/Mediawire): WHO has declared Hepatitis a major health concern for a developing nation like India. So it's time to...